The Education Of ODAC: How Sandoz Made Its Case For Biosimilarity

As the first biosimilar sponsor to present at an advisory committee, Sandoz had to educate FDA’s external experts about the general concepts of biosimilarity and the specific data surrounding its Zarxio development program.